Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LOC652694///IGKV1-5///IGKC |
| Upstream (Parents) |
|---|
| (<<) LOC100130100 → LOC652694///IGKV1-5///IGKC |
| Downstream (Children) |
|---|
| LOC652694///IGKV1-5///IGKC → LOC642131///IGHM///IGHG1///IGHA2///IGHA1///IGH@ (>>) |
| LOC652694///IGKV1-5///IGKC → IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ (>>) |
| LOC652694///IGKV1-5///IGKC → FAM20B (>>) |
| LOC652694///IGKV1-5///IGKC → LOC440871///IGK@///IGKV3-20///IGKV3D-11///IGKV3D-15///IGKC (>>) |
| LOC652694///IGKV1-5///IGKC → LOC100130100 (>>) |
| LOC652694///IGKV1-5///IGKC → IGKV4-1 (>>) |
| LOC652694///IGKV1-5///IGKC → LOC100133862///IGHM (>>) |
| LOC652694///IGKV1-5///IGKC → IGLV2-11///IGLV2-18///IGLV2-23 (>>) |
| LOC652694///IGKV1-5///IGKC → IGJ (>>) |
| LOC652694///IGKV1-5///IGKC → LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHD///IGHA1 (>>) |
| LOC652694///IGKV1-5///IGKC → TNFRSF17 (>>) |
| LOC652694///IGKV1-5///IGKC → IGLJ3 (>>) |
| LOC652694///IGKV1-5///IGKC → LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA1 (>>) |
| LOC652694///IGKV1-5///IGKC → IGLV6-57 (>>) |
| LOC652694///IGKV1-5///IGKC → MGC29506 (>>) |
| LOC652694///IGKV1-5///IGKC → PDX1 (>>) |
| LOC652694///IGKV1-5///IGKC → C8orf4 (>>) |
